Non-Radiographic Axial Spondyloarthritis (nr-axSpA) Latest Advances
Find the Latest Research About Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Non-Radiographic Axial Spondyloarthritis Presenting with Anterior Chest Wall Pain without Inflammatory Back Pain in an HLA-B27-Negative Young Man: A Case Report Highlighting Diagnostic Challenges.
Journal: International medical case reports journal
Published: July 09, 2026
Comparison of the established ASAS definition and preliminary proposed data-driven cut-offs for inflammatory and structural MRI lesions in the sacroiliac joints for eligibility of patients with nonradiographic axial spondyloarthritis in clinical trials.
Journal: Annals of the rheumatic diseases
Published: December 20, 2025
Challenges in diagnosing and monitoring radiographic and non-radiographic axial spondyloarthritis in daily clinical practice.
Journal: Clinical rheumatology
Published: November 08, 2025
Chinese recommendations for the diagnosis and management of non-radiographic axial spondyloarthritis.
Journal: Autoimmunity reviews
Published: August 03, 2025
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2.
Journal: RMD open
Published: January 02, 2024
Concept and understanding of non-radiographic axial spondyloarthritis
Journal: Zhonghua yi xue za zhi
Published: November 20, 2023
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).
Journal: Expert review of clinical immunology
Published: November 13, 2023
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.
Journal: Arthritis research & therapy
Published: September 25, 2023
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.
Journal: Clinical and translational science
Published: September 08, 2023
Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.
Journal: Rheumatology international
Published: August 07, 2023
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies.
Journal: Annals of the rheumatic diseases
Published: August 01, 2023
Last Updated: 11/08/2026